Adam's representative experience includes:

• The underwriters in Metsera's $275 million initial public offering.*
• Disc Medicine in its $259 million follow-on offering, $178 million follow-on offering, $200 million at-the-market offering, and $250 million follow-on offering.*
• Septerna, Inc. in its $288 million initial public offering.*
• The underwriters in PACS Group's $517 million initial public offering and $690 million primary and secondary follow on offering.*
• The initial purchasers in Ligand Pharmaceutical's $460.0 million aggregate principal amount of its 0.75% convertible senior notes due 2030.*
• Septerna, Inc. in its $2.2 billion Global Collaboration and License Agreement with Novo Nordisk.*
• Endeavor Group Holdings in its $511.3 million initial public offering and concurrent acquisition of the UFC.*
• The UFC in its $21.4 billion merger with WWE and creation of TKO Holdings.*
• Silver Lake Partners in its $12.5 billion acquisition and take-private of Qualtrics.*
• Shift4 Payments in its $345 million initial public offering, $485 million follow-on offering and $495 million secondary transaction offering.*
• Oddity Tech in its $424 million initial public offering.*
• The underwriters in Skyward Specialty Insurance's $134 million initial public offering, $153 million follow-on offering, and $89 million secondary follow-on offering.*
• Akero Therapeutics in its $367 million follow-on offering.*
• The placement agents in Outlook Therapeutics, Inc.'s $60 million PIPE financing.*
• The dealer manager in WeWork's exchange offer of $669 million senior notes.*
• The initial purchasers in Kaiser Aluminum's $500 million notes offering.*
• AVROBIO in its reverse merger with Tectonic Therapeutics and concurrent private placement.*
• Monte Rosa Therapeutics, Inc. in its $100 million follow-on offering.*
• ProMIS Neurosciences in its $122.7 million PIPE financing and $25 million at-the-market offering.*
• Rapid Micro Biosystems in its $10 million at-the-market offering.*
• The placement agent and sales agent in Acrivon Therapeutic's $130 million PIPE financing and $25 million at-the-market offering.*
• The initial purchasers in Icahn Enterprises' $750 million notes offering, $500 million notes offering, $300 million notes offering, $300 million notes offering, and $500 million notes offering.*
• Mister Car Wash in its $562.5 million initial public offering.*
• Venrock in Surrozen's $192 million PIPE financing.*

*Experience prior to joining White & Case.